Drug Standards
The field and scope of drug screening/analysis continues to expand worldwide. Example areas of focus include therapeutic drug monitoring, drugs of abuse, prescription monitoring, and clinical toxicology. The nature of those monitored or identified in the MS-based analysis include psychoactive drugs (e.g., benzodiazepines, cannabinoids, hallucinogens), pain-management drugs (e.g., analgesics, opiates, skeletal muscle relaxants), disorder-related treatment drugs (e.g., anticonvulsants /antiepileptics, antipsychotics), infectious disease or disease-related treatment drugs (e.g., antibiotics, antiarrhythmics), and antiviral drugs (e.g., antiobiotics, anticoagulants, anti-inflammatory agents). CIL is pleased to offer a broad collection of unlabeled and stable isotope-labeled standards to aid the qualitative/quantitative analysis of drugs and their metabolites. These encompass a multitude of classes and are available asindividual standards and/or class-specific mixtures in predominantly their concentrated solution form. For additional information on our drug standards, please view our Stable Isotope Standards for Mass Spectrometry catalog.
|